HEPATIC IMPAIRMENT DURING THE INTAKE OF CONTRACEPTIVE PILLS: CLINICAL TRIAL WITH POSTMENOPAUSAL WOMEN.
D000410:Alanine Transaminase; D000469:Alkaline Phosphatase / Q000097:blood*; D001219:Aspartate Aminotransferases; D001663:Bilirubin; D035843:Biomedical Research; D001774:Blood Chemical Analysis; D056486:Chemical and Drug Induced Liver Injury; D004796:Clinical Enzyme Tests; D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D051263:D-Alanine Transaminase; D004997:Ethinyl Estradiol; D006505:Hepatitis; D008111:Liver Function Tests; D017698:Postmenopause; D011372:Progestins; D013448:Sulfobromophthalein; D014116:Toxicology
D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D011372:Progestins; D013448:Sulfobromophthalein; D004997:Ethinyl Estradiol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D051263:D-Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin
ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD ALKALINE PHOSPHATASE; BLOOD CHEMICAL ANALYSIS; CLINICAL RESEARCH; CONTRACEPTIVES, ORAL; ENZYME TESTS; ETHINYL ESTRADIOL; HEPATITIS, TOXIC; LIVER FUNCTION TESTS; PROGESTATIONAL HORMONES; SULFOBROMOPHTHALEIN; TOXICOLOGIC REPORT